Search

everythinglearnresearchcommunity

for

Search:↓

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The document provides a comprehensive index of medical and surgical topics, including hair removal, hair restoration, and various treatments for injuries and conditions.

Alopecia areata in infants may be more common than previously thought.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Malassezia infection may cause refractory acne, and antifungal treatments can help.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Microbial biofilms may cause red scrotum syndrome.

Licorice has many health benefits but should be used carefully due to possible side effects.

Adult stem cells are effective and ethically acceptable for treating various diseases.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Mogamulizumab can cause hair loss and skin rashes.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Host cells are crucial for the maturation of reconstructed hair follicles.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Platelet-rich plasma (PRP) may improve healing in chronic wounds and vitiligo and promote hair regrowth, but more research is needed.